Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial

Autor: Choi, Jun-Young1, Park, Hyun-Jin2, Park, Sang-Min1 psmini@naver.com, Kang, Chang-Nam3, Song, Kwang-Sup4
Zdroj: Journal of Orthopaedic Surgery & Research. 8/31/2022, Vol. 17 Issue 1, p1-8. 8p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje